| Entry |
|
|---|
| Name |
Camylofin (INN);
Anafortan (TN) |
|---|
| Formula |
C19H32N2O2
|
|---|
| Exact mass |
320.2464
|
|---|
| Mol weight |
320.4696
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antispasmodic, Muscarinic acetylcholine receptor antagonist |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A03AA Synthetic anticholinergics, esters with tertiary amino group
A03AA03 Camylofin
D07076 Camylofin (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
D07076 Camylofin
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 23
1 C8x C 16.5900 -24.0100
2 C8x C 16.5900 -25.4100
3 C8x C 17.8024 -26.1100
4 C8x C 19.0149 -25.4100
5 C8x C 19.0149 -24.0100
6 C8y C 17.8024 -23.3100
7 C1c C 17.8024 -21.9102
8 C7a C 16.5732 -21.2003
9 N1b N 18.9980 -21.2198
10 O6a O 15.3692 -21.8954
11 O7a O 16.5734 -19.8101
12 C1b C 17.7984 -19.1030
13 C1b C 17.7985 -17.7101
14 C1b C 20.1852 -21.9052
15 C1b C 21.3766 -21.2172
16 N1c N 22.5659 -21.9039
17 C1b C 23.7562 -21.2166
18 C1b C 22.5661 -23.3098
19 C1a C 23.7590 -23.9985
20 C1a C 24.9461 -21.9036
21 C1c C 18.9971 -17.0181
22 C1a C 20.1856 -17.7044
23 C1a C 18.9973 -15.6103
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 7 9 1
10 8 10 2
11 8 11 1
12 11 12 1
13 12 13 1
14 9 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 16 18 1
19 18 19 1
20 17 20 1
21 13 21 1
22 21 22 1
23 21 23 1
|
|---|
